Skip to main content
Signal8

Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics, Inc. operates as a clinical-stage biotechnology company, primarily focused on the creation and commercialization of anti-inflammatory treatments for individuals suffering from chronic rhinosinusitis (CRS). The company's unique technological approach allows for the direct delivery of therapeutic agents to the targeted tissue, ensuring prolonged efficacy from a singular dose. Its pipeline features several promising candidates, including LYR-210, an anti-inflammatory implantable drug matrix currently in Phase III clinical trials for CRS. Additionally, LYR-220 is under development for CRS patients who have not responded to previous medical treatments and still require intervention for their symptoms. Lyra has forged a partnership with LianBio Inflammatory Limited to facilitate the development and market entry of LYR-210 throughout specific Asian regions, encompassing mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. Established in 2005, the company was initially known as 480 Biomedical, Inc. before adopting the name Lyra Therapeutics, Inc. in July 2018. Its corporate headquarters are located in Watertown, Massachusetts.

Sector: Biotechnology

Industry: Biotechnology

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

OTC:LYRAHealthcare
-84.21%$0.0300
CLOSED
Mkt Cap$337K
EV-
Float1.34M
O/S11.24M
VOL8K sh
$ Vol$244
RVOL1.97×
Inst Own-
SI0.4%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Lyra Therapeutics, Inc. logoOTC:LYRAClosed$0.0300-84.21%
Financials Summary
Revenue$398K
Net Income-$28.92M
Total Assets$36.11M
Free Cash Flow-$28.98M
Debt & Equity
Debt 155%
Total Debt$30.26M
Total Equity-$10.72M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:50

Nasdaq bars a compliance period at 1:250

  1. 1:50Reverse split
    May 28, 202550 shares → 1
Balance Sheet Details
Assets$36.11M
Liabilities$46.83M
Accounts Receivable$0
Accounts Payable$663K
Inventory$0
PP&E (Net)$17.84M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue$398K$1.53M$1.56M$1.36M$285K$0$0$1.24M
YoY Growth-74.1%-1.5%14.3%378.2%----
Cost of Revenue$0$0$0$0$29.69M$12.52M$0$0
Gross Profit$398K$1.53M$1.56M$1.36M-$29.41M-$12.52M$0$1.24M
Gross Margin100.0%100.0%100.0%100.0%-10318.9%--100.0%
Research and Development$18.41M$43.77M$48.03M$38.8M$29.69M$12.52M$12.03M$4.97M
Selling, General, and Administrative$11.54M$18.5M$19.06M$17.56M$14.21M$9.69M$4.49M$3.53M
Other$0$35.62M$1.59M$1.32M-$29.69M-$12.52M-$1$0
Total Operating Expenses$29.95M$97.88M$68.68M$57.67M$14.21M$9.69M$16.52M$8.5M
Operating Income (EBIT)-$31.02M-$96.35M-$67.12M-$56.31M-$43.62M-$22.21M-$16.52M-$7.26M
Operating Margin-7794.5%-6280.8%-4308.1%-4131.0%-15303.5%---583.5%
Interest Expense$0$0$0$0$0$0$0$0
Interest Income$1.13M$2.95M$4.5M$1.04M$102K$82K$213K$36K
Other Income (Expense)$2.11M$2.95M$4.5M$1.04M$102K$82K$213K$1.23M
Income Before Tax (EBT)-$28.91M-$93.4M-$62.62M-$55.27M-$43.51M-$22.13M-$16.31M-$6.03M
Income Tax Expense$11K$39K$59K$13K$0$0$0$0
Net Income-$28.92M-$93.44M-$62.68M-$55.28M-$43.51M-$22.13M-$16.31M-$6.03M
Net Income Margin-7266.1%-6090.9%-4023.1%-4055.6%-15267.7%---484.6%
Supplementary Data
EPS-18.62-1.43-1.26-1.83-3.35-2.59-62.50-0.98
Diluted EPS-18.62-1.43-1.26-1.83-3.35-2.59-62.50-0.98
Weighted Average OS15.53M65.11M49.75M30.24M12.99M8.55M8.18M6.27M
EBITDA-$29.09M-$60.26M-$65.25M-$53.92M-$42.61M-$22.11M-$16.49M-$7.18M
EBITDA Margin-7310.1%-3928.4%-4188.1%-3956.2%-14952.3%---576.9%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Assets
Current Assets
Cash and Cash Equivalents$15.89M$40.58M$22.35M$32.55M$45.75M$74.59M$9.81M$23.89M
Short-Term Investments$0$0$80.4M$65.34M$0$0$0$0
Cash and Short-Term Investments$15.89M$40.58M$102.75M$97.89M$45.75M$74.59M$9.81M$23.89M
Accounts Receivable$0$0$0$0$0$0$0$167K
Inventory$0$0$0$0$0$0$0$0
Other Current Assets$379K$2.45M$2.07M$2.94M$0$0$0$0
Total Current Assets$16.27M$43.02M$104.82M$100.83M$47.92M$75.92M$10.12M$24.93M
Long-Term Assets
Property, Plant & Equipment Net$17.84M$21.33M$35.28M$4.47M$5.86M$4.47M$3.42M$103K
Goodwill$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0
Long-Term Investments$0$1.99M$1.39M$0$0$0$329K$329K
Deferred Tax Assets$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.99M$0$1.11M$4.67M$1.09M$447K$1.1M$0
Total Long-Term Assets$19.84M$23.32M$37.78M$9.14M$6.95M$4.91M$4.84M$432K
Other Assets$0$0$0$0$0$0$0$0
Total Assets$36.11M$66.35M$142.6M$109.97M$54.87M$80.83M$14.96M$25.36M
Liabilities
Current Liabilities
Accounts Payable$663K$1.18M$3.13M$2.62M$3.13M$922K$1.07M$631K
Short-Term Debt$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0
Current Unearned Revenue$11.86M$398K$1.66M$1.27M$9.79M$0$3.13M$0
Other Current Liabilities-$7.82M$4.82M$1.23M$659K$633K$149K-$3.02M$845K
Total Current Liabilities$9.52M$12.63M$19.6M$14.47M$18.25M$4.88M$5.21M$1.96M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$11.86M$12.14M$14.08M$1.93M$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$11.86M$0$0$0$0$0$0$130.47M
Total Long-Term Liabilities$37.3M$42.12M$33.58M$14.74M$2.31M$1.45M$2.43M$130.47M
Other Liabilities$0$0$0$0$0$0$0$0
Total Liabilities$46.83M$54.75M$53.18M$29.21M$20.55M$6.34M$7.63M$132.43M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$130.67M$130.35M
Common Stock$2K$65K$57K$32K$13K$13K$6K$6K
Retained Earnings-$433.71M-$404.79M-$311.36M-$248.68M-$193.4M-$149.88M-$127.76M-$111.45M
Comprehensive Income & Other$0$0$33K$10K$0-$0$0-$2.8M
Other Stockholders' Equity$422.99M$416.32M$400.72M$329.4M$227.7M$224.36M$135.08M$4.37M
Total Equity-$10.72M$11.59M$89.42M$80.75M$34.32M$74.49M$7.33M-$107.07M
Minority Interest$0$0$0$0$0$0$0$0
Total Liabilities and Equity$36.11M$66.35M$142.6M$109.97M$54.87M$80.83M$14.96M$25.36M
Supplementary Data
Total Debt$30.26M$34.38M$26.88M$4.18M$1.45M$2.44M$3.33M$0
Net Debt$14.37M-$6.2M$4.53M-$28.37M-$44.29M-$72.15M-$6.48M-$23.89M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Operating Activities
Net Income-$28.92M-$93.44M-$62.68M-$55.28M-$43.51M-$22.13M-$16.31M-$6.03M
Depreciation & Amortization$459K$471K$278K$1.07M$1M$95K$27K$82K
Deferred Income Tax$0$0$0$0-$2.42M$0$0$0
Stock-Based Compensation$2.33M$6.72M$5.89M$5.45M$2.77M$1.81M$244K$406K
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$164K
  Inventory$0$0$0$0$0$0$0$0
  Accounts Payable-$516K-$1.89M$450K-$2.41M$2.35M$345K-$205K$134K
  Other Working Capital-$2.21M-$4.46M-$5.33M$6.97M$11.57M-$1.22M$2.32M-$55K
Total Working Capital Change-$2.73M-$6.35M-$4.88M$4.55M$13.92M-$879K$2.11M$79K
Other Non-Cash Items-$8K$22.58M-$1.9M$824K$2.42M-$45K$167K-$1.18M
Net Cash from Operating-$28.86M-$70.01M-$63.3M-$43.38M-$25.82M-$21.14M-$13.75M-$6.64M
Investing Activities
Capital Expenditures-$116K-$2.34M-$1.05M-$164K-$3.38M-$1.77M-$211K-$37K
Acquisitions$0$0$0$0$0$0$0$0
Purchases of Investments$0-$47.95M-$122.42M-$64.84M$0$0$0$0
Sales of Investments$0$130.59M$110.89M$0$0$0$0$0
Other Investing Activities$18K$0$0$0$0$0$0$0
Net Cash from Investing-$98K$80.31M-$12.58M-$65.01M-$3.38M-$1.77M-$211K-$37K
Financing Activities
Debt Repaid--------$500K
Common Stock Issuance$5M$8.82M$69.24M$100.5M$604K$59.89M$111K$12K
Common Stock Repurchases$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0
Other Financing Activities-$726K-$287K-$3.55M-$4.24M-$245K-$2.58M-$226K$28.71M
Net Cash from Financing$4.27M$8.53M$65.69M$96.26M$359K$87.7M-$115K$29.21M
Forex Effect$0$0$0$0$0$0$0$0
Net Change in Cash-$24.68M$18.82M-$10.2M-$12.13M-$28.85M$64.78M-$14.08M$22.54M
Supplementary Data
Operating Cash Flow-$28.86M-$70.01M-$63.3M-$43.38M-$25.82M-$21.14M-$13.75M-$6.64M
Capital Expenditure-$116K-$2.34M-$1.05M-$164K-$3.38M-$1.77M-$211K-$37K
Free Cash Flow-$28.98M-$72.35M-$64.35M-$43.55M-$29.2M-$22.92M-$13.96M-$6.68M
Cash at Beginning$42.57M$23.75M$33.94M$46.08M$74.92M$10.14M$23.89M$1.68M
Cash at End$17.89M$42.57M$23.75M$33.94M$46.08M$74.92M$9.81M$24.22M